Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2012

01-12-2012 | Erratum

Erratum to: Women’s features and inter-/intra-rater agreement on mammographic density assessment in full-field digital mammograms (DDM-SPAIN)

Authors: Beatriz Pérez-Gómez, Franciso Ruiz, Inmaculada Martínez, María Casals, Josefa Miranda, Carmen Sánchez-Contador, Carmen Vidal, Rafael Llobet, Marina Pollán, Dolores Salas

Published in: Breast Cancer Research and Treatment | Issue 3/2012

Login to get access

Excerpt

Unfortunately, in the original publication of the article, the grant number in the funding information has been published incorrectly. The correct funding information in the acknowledgement section should read as “grants FIS PI09/0790 & PI060386 from Spain’s Health Research Fund (Fondo de Investigación Sanitaria)”. …
Metadata
Title
Erratum to: Women’s features and inter-/intra-rater agreement on mammographic density assessment in full-field digital mammograms (DDM-SPAIN)
Authors
Beatriz Pérez-Gómez
Franciso Ruiz
Inmaculada Martínez
María Casals
Josefa Miranda
Carmen Sánchez-Contador
Carmen Vidal
Rafael Llobet
Marina Pollán
Dolores Salas
Publication date
01-12-2012
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2012
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-012-2319-7

Other articles of this Issue 3/2012

Breast Cancer Research and Treatment 3/2012 Go to the issue

Review

Use of antidepressants and the risk of breast cancer: a meta-analysis

Epidemiology

Germline mutations in RAD51C in Jewish high cancer risk families

Clinical Trial

Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study

Epidemiology

Plasma matrix metalloproteinases and postmenopausal breast cancer risk: a nested case–control study in the Multiethnic Cohort study

Preclinical Study

Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer

Epidemiology

Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits